Prescribing Info: gskp.ro/3zmFMLH Is dosing schedule important to your COPD patients with an eosinophilic phenotype? Learn about this once-monthly treatment. For US healthcare professional audience only. Trademarks are owned by or licensed to the

This is an HCP ad for OJJAARA, a prescription medicine used specifically to treat adults with certain types of myelofibrosis who have anemia.

This is an unbranded Linkedin carousel ad for COPD.

NUCALA is a biologic for the treatment of COPD and asthma with an eosinophilic phenotype.

TRELEGY is a combination inhaler designed to treat COPD and asthma in adults.

This is an HCP site for OJJAARA, a medication to treat adults with certain types of myelofibrosis who have anemia.

This is an HCP ad for BENLYSTA, a biologic to treat Lupus.

This is an HCP site for BLENREP, a medication for adult patients with relapsed or refractory multiple myeloma.

How to prescribe